Your browser doesn't support javascript.
loading
Clinical Experience of Immunotherapy Treatment: Efficacy and Toxicity Analysis of the Compassionate Use Program of Nivolumab in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer.
Krefting, Frederik; Basara, Nadezda; Schütte, Wolfgang; Späth-Schwalbe, Ernst; Alt, Jürgen; Thiel, Sebastian; Kimmich, Martin; Fischer, Jürgen R; Kurz, Sylke; Griesinger, Frank; Christoph, Daniel C.
Afiliación
  • Krefting F; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany, Frederik.krefting@online.de.
  • Basara N; Department of Hematology and Oncology, Malteser Clinic St. Franziskus-Hospital, Flensburg, Germany.
  • Schütte W; Department of Internal Medicine II, Martha-Maria Hospital Halle-Dölau, Halle, Germany.
  • Späth-Schwalbe E; Department of Hematology and Oncology, Vivantes Clinic Spandau, Berlin, Germany.
  • Alt J; Department of Internal Medicine III, Universitätsmedizin Mainz, Mainz, Germany.
  • Thiel S; Department of Pneumology, Helios Clinic Emil von Behring, Berlin, Germany.
  • Kimmich M; Department of Pneumology, Clinic Schillerhoehe, Gerlingen, Germany.
  • Fischer JR; Department of Internal Medicine II, Lungenklinik Löwenstein GmbH, Löwenstein, Germany.
  • Kurz S; Department of Pneumology, Protestant Lung Hospital, Berlin, Germany.
  • Griesinger F; Department of Hematology and Oncology, Pius Hospital Oldenburg, Oldenburg, Germany.
  • Christoph DC; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
Oncol Res Treat ; 42(5): 243-255, 2019.
Article en En | MEDLINE | ID: mdl-30995666

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Ensayos de Uso Compasivo / Nivolumab / Inmunoterapia / Neoplasias Pulmonares Idioma: En Revista: Oncol Res Treat Año: 2019 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Ensayos de Uso Compasivo / Nivolumab / Inmunoterapia / Neoplasias Pulmonares Idioma: En Revista: Oncol Res Treat Año: 2019 Tipo del documento: Article